Emergent BioSolutions Inc (EBS)
1.925
-0.02
(-1.28%)
USD |
NYSE |
Apr 26, 16:00
1.96
+0.04
(+1.82%)
After-Hours: 20:00
Emergent BioSolutions Cash from Investing (TTM): 212.30M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | 212.30M |
| September 30, 2023 | 178.30M |
| June 30, 2023 | -74.40M |
| March 31, 2023 | -364.20M |
| December 31, 2022 | -381.30M |
| September 30, 2022 | -381.70M |
| June 30, 2022 | -165.30M |
| March 31, 2022 | -200.20M |
| December 31, 2021 | -224.10M |
| September 30, 2021 | -215.20M |
| June 30, 2021 | -205.70M |
| March 31, 2021 | -183.80M |
| December 31, 2020 | -151.90M |
| September 30, 2020 | -151.10M |
| June 30, 2020 | -120.70M |
| March 31, 2020 | -99.70M |
| December 31, 2019 | -96.90M |
| September 30, 2019 | -909.30M |
| June 30, 2019 | -920.10M |
| March 31, 2019 | -907.00M |
| December 31, 2018 | -897.20M |
| September 30, 2018 | -256.22M |
| June 30, 2018 | -242.90M |
| March 31, 2018 | -241.20M |
| December 31, 2017 | -249.90M |
| Date | Value |
|---|---|
| September 30, 2017 | -62.34M |
| June 30, 2017 | -66.56M |
| March 31, 2017 | -78.29M |
| December 31, 2016 | -76.20M |
| September 30, 2016 | -68.07M |
| June 30, 2016 | -65.03M |
| March 31, 2016 | -54.59M |
| December 31, 2015 | -45.46M |
| September 30, 2015 | -50.90M |
| June 30, 2015 | -42.17M |
| March 31, 2015 | -36.38M |
| December 31, 2014 | -210.05M |
| September 30, 2014 | -202.14M |
| June 30, 2014 | -241.34M |
| March 31, 2014 | -242.97M |
| December 31, 2013 | -67.89M |
| September 30, 2013 | -71.44M |
| June 30, 2013 | -37.05M |
| March 31, 2013 | -39.20M |
| December 31, 2012 | -40.11M |
| September 30, 2012 | -45.55M |
| June 30, 2012 | -51.34M |
| March 31, 2012 | -49.82M |
| December 31, 2011 | -53.96M |
| September 30, 2011 | -45.04M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-920.10M
Minimum
Jun 2019
212.30M
Maximum
Dec 2023
-234.47M
Average
-183.80M
Median
Mar 2021
Cash from Investing (TTM) Benchmarks
| Avid Bioservices Inc | -51.17M |
| Viking Therapeutics Inc | -641.08M |
| FibroGen Inc | 153.66M |
| Avinger Inc | -0.008M |
| RAPT Therapeutics Inc | 104.13M |